Abstract Tumor Treating Fields (TTFields) therapy is a cancer treatment modality based on continuous, non-invasive delivery of electric fields. TTFields therapy is approved for treatment of glioblastoma (GBM), delivered to the patient’s brain by two array pairs placed on the scalp. Further research in animals to expand the knowledge regarding TTFields treatment of GBM is limited, as this is mainly performed in mouse models and arrays for application of TTFields to the mouse head are lacking. The small dimensions and specific geometries of the mouse head make the development of such arrays challenging. The aim of this study was to design arrays that will allow efficient and stable delivery of TTFields to the mouse head. To overcome the small head size, we developed a layout with two arrays situated on the head of the mouse, each divided into two smaller disks, and positioned opposite two arrays on the torso. We identified a thin and transparent adhesive tape (facilitating correct array positioning) with good tackiness and easy removal (without leaving residual adhesive on the skin). The arrays met the minimum treatment requirements: current ≥ 50 mA, usage ≥ 75%, field intensity ≥ 1 V/cm RMS. We then conducted an efficacy study with the new arrays, using GL-261 GBM cells intracranially injected into C57BL/6 mice. Treatment with sham-heat (control) or TTFields was initiated 11 days following tumor inoculation and maintained continuously for 12 days. Efficacy was measured via magnetic resonance imaging (MRI) of tumor volume, showing a decrease of 31% at treatment end in TTFields-treated mice versus the control. Overall, the new arrays are flexible, strongly adherent, deliver TTFields at a sufficient intensity, and showed efficacy for treating GBM in mice.
Read full abstract